Court Documents Reveal What’s Next for Amazon’s Health-Care “Disruption”

Amazon, Berkshire Hathaway, and JPMorgan Chase are in the early stages of launching a joint venture to redesign health care. The partnership is yet to be named, but, according to newly unsealed court testimony from COO Jack Stoddard, the company is studying how pharmacies work, how to better understand a drug’s true price, and what factors make a person more or less likely or able to take a drug as prescribed.

The testimony is from a lawsuit filed by Optum, the prescription drug unit of insurer UnitedHealth Group. Optum is seeking a court order to block its former executive David Smith from sharing corporate secrets. Mr. Stoddard noted that his new company will not replace pharmacy benefit managers like Optum.

It appears that a main goal of the company is to bolster the importance of primary care and make access to quality providers easier. The venture wants to “make it easier for doctors to do good care and to spend more time, not less time” providing care, Mr. Stoddard said.

Source: STAT News, February 20, 2019; The Wall Street Journal, February 20, 2019.